Literature DB >> 22870127

Medullary thyroid carcinoma: The third most common thyroid cancer reviewed.

Michael Stamatakos1, Panoraia Paraskeva, Charikleia Stefanaki, Paraskevas Katsaronis, Andreas Lazaris, Konstantinos Safioleas, Konstantinos Kontzoglou.   

Abstract

Medullary thyroid cancer is a type of thyroid cancer of neuroendocrine origin. It occurs in hereditary and sporadic forms, and its aggressive behavior is associated with the clinical presentation and type of RET mutation. Total thyroidectomy remains the ideal choice of treatment. Early diagnosis and treatment are the fundamental for a 100% cure rate. In this study, we present our experience of 3 cases, along with a complete review of the literature derived from a Pubmed Database search.

Entities:  

Year:  2010        PMID： 22870127      PMCID： PMC3412473          DOI： 10.3892/ol.2010.223

Source DB:  PubMed          Journal:  Oncol Lett        ISSN： 1792-1074            Impact factor:   2.967


  27 in total

Review 1.  Medullary thyroid carcinoma.

Authors:  D B Evans; M A Burgess; H Goepfert; R F Gagel
Journal:  Curr Ther Endocrinol Metab       Date:  1997

2.  Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases.

Authors:  Sanziana Roman; Rong Lin; Julie Ann Sosa
Journal:  Cancer       Date:  2006-11-01       Impact factor: 6.860

Review 3.  Current approaches to medullary thyroid carcinoma, sporadic and familial.

Authors:  Elizabeth A Fialkowski; Jeffrey F Moley
Journal:  J Surg Oncol       Date:  2006-12-15       Impact factor: 3.454

Review 4.  Medullary thyroid carcinoma--update and present management controversies.

Authors:  Mahir Al-Rawi; Malcolm H Wheeler
Journal:  Ann R Coll Surg Engl       Date:  2006-09       Impact factor: 1.891

Review 5.  Surgical approaches in thyroid cancer and lymph-node metastases.

Authors:  Henning Dralle; Andreas Machens
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2008-12       Impact factor: 4.690

Review 6.  Surgical approach to medullary thyroid cancer.

Authors:  Catharina Ihre Lundgren; Leigh Delbridg; Diana Learoyd; Bruce Robinson
Journal:  Arq Bras Endocrinol Metabol       Date:  2007-07

Review 7.  Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma.

Authors:  Vittoria Rufini; Paola Castaldi; Giorgio Treglia; Germano Perotti; Milton D Gross; Adil Al-Nahhas; Domenico Rubello
Journal:  Biomed Pharmacother       Date:  2007-08-20       Impact factor: 6.529

8.  Sonography and fine-needle aspiration biopsy in the diagnosis of benign versus malignant nodules in patients with autoimmune thyroiditis.

Authors:  Feng-Hsuan Liu; Chuen Hsueh; Hung-Yu Chang; Miaw-Jene Liou; Bie-Yu Huang; Jen-Der Lin
Journal:  J Clin Ultrasound       Date:  2009 Nov-Dec       Impact factor: 0.910

9.  Neck management in medullary thyroid carcinoma.

Authors:  I M Oskam; F Hoebers; A J M Balm; F van Coevorden; E M Bais; A M Hart; M W M van den Brekel
Journal:  Eur J Surg Oncol       Date:  2007-06-06       Impact factor: 4.424

10.  Current management of medullary thyroid cancer.

Authors:  Rebecca S Sippel; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Oncologist       Date:  2008-05
View more
  2 in total

1.  Calcitonin negative medullary thyroid cancer in ectopic thyroid tissue: a rare diagnosis in an unusual location.

Authors:  Gareth Montgomery; Laurence Collins; Caroline Coghlin; Ramzan Ullah
Journal:  BMJ Case Rep       Date:  2020-08-18

2.  In silico Analysis of Publicly Available Transcriptomics Data Identifies Putative Prognostic and Therapeutic Molecular Targets for Papillary Thyroid Carcinoma.

Authors:  Asma Almansoori; Poorna Manasa Bhamidimarri; Riyad Bendardaf; Rifat Hamoudi
Journal:  Int J Gen Med       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.